Interestingly, the nuclear receptor, peroxisome proliferator-activated receptor-gamma (PPARγ) has been recognized as a therapeutic target for various neurodegenerative disorders such as Alzheimer's (AD), Parkinson's (PD), and HD [5]. Here, PPARG is linked to Alzheimer disease.